A CIRCULATING EXOSOMAL MICRORNA SIGNATURE FOR THE NONINVASIVE PREDICTION OF RESPONSE TO THE FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC GASTRIC CANCER

被引：0
|
作者：
Okuno, Keisuke
Watanabe, Shuichi
Hur, Hoon
Lee, Jeeyun
Tokunaga, Masanori
Kinugasa, Yusuke
Goel, Ajay
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1125
引用
收藏
页码：S766 / S766
页数：1
相关论文
共 50 条
  • [41] Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Ying Wang
    Ping Liu
    Yan Xu
    Weihao Zhang
    Lina Tong
    Zhi Guo
    Hong Ni
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 255 - 262
  • [42] Early switching to pembrolizumab (Pe) during first-line platinum-based chemotherapy (PCT) in patients (pts) with metastatic urothelial carcinoma (mUC).
    Endo, Yuki
    Kimura, Go
    Akatsuka, Jun
    Takeda, Hayato
    Yanagi, Masato
    Mikami, Hikaru
    Hasegawa, Hiroya
    Taniuchi, Mami
    Katsu, Akifumi
    Funato, Ryota
    Toyama, Yuka
    Kondo, Yukihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [43] Fluoropyrimidine/platinum-based first-line chemotherapy in metastatic esophageal squamous cell carcinoma: Prognostic factor analysis in 239 patients.
    Jung, H. A.
    Lee, J.
    Ahn, H. K.
    Park, S. H.
    Park, Y. H.
    Im, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy
    Sharma, Padmanee
    Sohn, Joohyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Gizzi, Marco
    Kalinka, Ewa
    de Vos, Filip Y. F. L.
    Ruscica, Dario
    Ferro, Salvatore
    Xiao, Feng
    Baverel, Paul
    Chen, Cecil Chi-Keung
    Asubonteng, Kobby
    Morsli, Nassim
    Dirix, Luc
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 61 - 70
  • [45] FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
    Arslan, C.
    Kilickap, S.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1149 - 1150
  • [46] The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma
    Okita, Kazutaka
    Hatakeyama, Shingo
    Hagiwara, Kazuhisa
    Suzuki, Yuichiro
    Tanaka, Toshikazu
    Noro, Daisuke
    Tokui, Noriko
    Fujita, Naoki
    Konishi, Sakae
    Okamoto, Teppei
    Yoneyama, Tohru
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 832.e17 - 832.e23
  • [47] KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
    Ghimessy, Aron Kristof
    Gellert, Aron
    Schlegl, Erzsebet
    Hegedus, Balazs
    Raso, Erzsebet
    Barbai, Tamas
    Timar, Jozsef
    Ostoros, Gyula
    Megyesfalvi, Zsolt
    Gieszer, Balazs
    Moldvay, Judit
    Renyi-Vamos, Ferenc
    Lohinai, Zoltan
    Hoda, Mir Alireza
    Klikovits, Thomas
    Klepetko, Walter
    Laszlo, Viktoria
    Dome, Balazs
    CANCERS, 2019, 11 (10)
  • [48] Prognostic Factors in First-Line Chemotherapy Treated Metastatic Gastric Cancer Patients: A Retrospective Study
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Guven, Mehmet
    Nas, Necip
    Yunce, Muharrem
    Isikdogan, Abdurrahman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3869 - 3872
  • [49] First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
    Lin, Zuan
    Fu, Sha
    Zhou, Yixin
    Zhang, Xuanye
    Chen, Chen
    He, Li-na
    Li, Haifeng
    Wang, Yuhong
    Chen, Tao
    Zhang, Li
    Hong, Shaodong
    LUNG CANCER, 2019, 137 : 100 - 107
  • [50] Thromboembolic events (TE) in patients with metastatic non small cell lung cancer (NSCLC) EGFR/ALK native treated with first-line platinum-based chemotherapy
    Castellon Rubio, V. E.
    Luque Caro, R.
    Gonzalez Flores, E.
    Canosa Ruiz, L.
    ANNALS OF ONCOLOGY, 2015, 26 : 116 - 116
12345